Dr .Kaftan first joined Yale School of Medicine in 2012 as an associate research scientist in the pharmacology department. He joined the medical oncology section in 2014 has since overseen Yale Cancer Center’s translational science research efforts alongside Roh Herbst, MD, PhD.
Dr. Kaftan worked in research at Wyeth Research, Pfizer Pharmaceuticals and R.W. Johnson PHarmaceutical Research Institute before joining Yale.
He succeeds Robert Garofalo, PhD, who is retiring at the end of this year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
